CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

Julia E. Maxson; Rhonda E. Ries; Yi Cheng Wang; Robert B. Gerbing; E. Anders Kolb; Sarah L. Thompson; Jaime M.Guidry Auvil; Marco A. Marra; Yussanne Ma; Zusheng Zong; Andrew J. Mungall; Richard Moore; William Long; Patee Gesuwan; Tanja M. Davidsen; Leandro C. Hermida; Seamus B. Hughes; Jason E. Farrar; Jerald P. Radich; Malcolm A. Smith; Daniela S. Gerhard; Alan S. Gamis; Todd A. Alonzo; Soheil Meshinchi

doi:10.1182/blood-2016-04-709899

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

Julia E. Maxson, Rhonda E. Ries, Yi Cheng Wang, Robert B. Gerbing, E. Anders Kolb, Sarah L. Thompson, Jaime M.Guidry Auvil, Marco A. Marra, Yussanne Ma, Zusheng Zong, Andrew J. Mungall, Richard Moore, William Long, Patee Gesuwan, Tanja M. Davidsen, Leandro C. Hermida, Seamus B. Hughes, Jason E. Farrar, Jerald P. Radich, Malcolm A. SmithDaniela S. Gerhard, Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi

Research output: Contribution to journal › Letter › peer-review

42 Scopus citations

Original language	English (US)
Pages (from-to)	3094-3098
Number of pages	5
Journal	Blood
Volume	127
Issue number	24
DOIs	https://doi.org/10.1182/blood-2016-04-709899
State	Published - Jun 16 2016
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2016-04-709899

Cite this

Maxson, J. E., Ries, R. E., Wang, Y. C., Gerbing, R. B., Kolb, E. A., Thompson, S. L., Auvil, J. M. G., Marra, M. A., Ma, Y., Zong, Z., Mungall, A. J., Moore, R., Long, W., Gesuwan, P., Davidsen, T. M., Hermida, L. C., Hughes, S. B., Farrar, J. E., Radich, J. P., ... Meshinchi, S. (2016). CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML. Blood, 127(24), 3094-3098. https://doi.org/10.1182/blood-2016-04-709899

Maxson, JE, Ries, RE, Wang, YC, Gerbing, RB, Kolb, EA, Thompson, SL, Auvil, JMG, Marra, MA, Ma, Y, Zong, Z, Mungall, AJ, Moore, R, Long, W, Gesuwan, P, Davidsen, TM, Hermida, LC, Hughes, SB, Farrar, JE, Radich, JP, Smith, MA, Gerhard, DS, Gamis, AS, Alonzo, TA & Meshinchi, S 2016, 'CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML', Blood, vol. 127, no. 24, pp. 3094-3098. https://doi.org/10.1182/blood-2016-04-709899

@article{d7b8b3e8b40d429d8ad4a5cd99fdfbf6,

title = "CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML",

author = "Maxson, {Julia E.} and Ries, {Rhonda E.} and Wang, {Yi Cheng} and Gerbing, {Robert B.} and Kolb, {E. Anders} and Thompson, {Sarah L.} and Auvil, {Jaime M.Guidry} and Marra, {Marco A.} and Yussanne Ma and Zusheng Zong and Mungall, {Andrew J.} and Richard Moore and William Long and Patee Gesuwan and Davidsen, {Tanja M.} and Hermida, {Leandro C.} and Hughes, {Seamus B.} and Farrar, {Jason E.} and Radich, {Jerald P.} and Smith, {Malcolm A.} and Gerhard, {Daniela S.} and Gamis, {Alan S.} and Alonzo, {Todd A.} and Soheil Meshinchi",

note = "Funding Information: The authors gratefully acknowledge the important contributions of the late Robert Arceci to the AML TARGET initiative. The TARGET initiative is supported by a grant from the National Institutes of Health National Cancer Institute (U10 CA98543). Work performed under contracts from the National Cancer Institute (HHSN261200800001E) include: specimen processing (COG Biopathology Center) and whole genomic sequencing (Complete Genomics, Inc.). This work is also supported by the JJ's Angels St. Baldrick's research grant (#360525) (J.E.M. and S.M.). J.E.M. is supported by a K99/R00 award from the National Cancer Institute (CA190605-02); Y.-C.W. is supported by the Andrew McDonough B1 Foundation; S.M. is supported by a grant from the National Cancer Institute (5R01CA114563), a St. Baldrick's Foundation Consortium Research Grant (#280920), TARGET (3U01CA098543), and a COG chair's grant (3U10CA180886); J.E.F. is supported by the Arkansas Biosciences Institute; and T.A.A. is supported by the COG Statistics and Data Center (1U10CA180899) and COG chair's grant (5U10CA098543). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.",

year = "2016",

month = jun,

day = "16",

doi = "10.1182/blood-2016-04-709899",

language = "English (US)",

volume = "127",

pages = "3094--3098",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "24",

}

TY - JOUR

T1 - CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

AU - Maxson, Julia E.

AU - Ries, Rhonda E.

AU - Wang, Yi Cheng

AU - Gerbing, Robert B.

AU - Kolb, E. Anders

AU - Thompson, Sarah L.

AU - Auvil, Jaime M.Guidry

AU - Marra, Marco A.

AU - Ma, Yussanne

AU - Zong, Zusheng

AU - Mungall, Andrew J.

AU - Moore, Richard

AU - Long, William

AU - Gesuwan, Patee

AU - Davidsen, Tanja M.

AU - Hermida, Leandro C.

AU - Hughes, Seamus B.

AU - Farrar, Jason E.

AU - Radich, Jerald P.

AU - Smith, Malcolm A.

AU - Gerhard, Daniela S.

AU - Gamis, Alan S.

AU - Alonzo, Todd A.

AU - Meshinchi, Soheil

N1 - Funding Information: The authors gratefully acknowledge the important contributions of the late Robert Arceci to the AML TARGET initiative. The TARGET initiative is supported by a grant from the National Institutes of Health National Cancer Institute (U10 CA98543). Work performed under contracts from the National Cancer Institute (HHSN261200800001E) include: specimen processing (COG Biopathology Center) and whole genomic sequencing (Complete Genomics, Inc.). This work is also supported by the JJ's Angels St. Baldrick's research grant (#360525) (J.E.M. and S.M.). J.E.M. is supported by a K99/R00 award from the National Cancer Institute (CA190605-02); Y.-C.W. is supported by the Andrew McDonough B1 Foundation; S.M. is supported by a grant from the National Cancer Institute (5R01CA114563), a St. Baldrick's Foundation Consortium Research Grant (#280920), TARGET (3U01CA098543), and a COG chair's grant (3U10CA180886); J.E.F. is supported by the Arkansas Biosciences Institute; and T.A.A. is supported by the COG Statistics and Data Center (1U10CA180899) and COG chair's grant (5U10CA098543). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.

PY - 2016/6/16

Y1 - 2016/6/16

UR - http://www.scopus.com/inward/record.url?scp=84976309530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976309530&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-04-709899

DO - 10.1182/blood-2016-04-709899

M3 - Letter

C2 - 27143256

AN - SCOPUS:84976309530

SN - 0006-4971

VL - 127

SP - 3094

EP - 3098

JO - Blood

JF - Blood

IS - 24

ER -

CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this